UNICREDIT BANK/CALL/INTUITIVE SURGICAL/350/0.1/19.06.24 Share Price

Warrant

DE000HC3L662

Market Closed - BOERSE MUENCHEN 01:11:28 01/06/2024 am IST
4.65 EUR -6.06% Intraday chart for UNICREDIT BANK/CALL/INTUITIVE SURGICAL/350/0.1/19.06.24
1 month+62.02%
3 months-4.91%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
31/24/31 4.65 -6.06%
30/24/30 4.95 +7.38%
29/24/29 4.61 -3.35%
28/24/28 4.77 -10.34%
27/24/27 5.32 +1.33%

Real-time BOERSE MUENCHEN

Last update May 01, 2024 at 01:11 am IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying INTUITIVE SURGICAL, INC.
IssuerLogo Issuer UniCredit UniCredit
WKN HC3L66
ISINDE000HC3L662
Date issued 27/01/2023
Strike 350 $
Maturity 19/06/2024 (17 Days)
Parity 10 : 1
Emission price 1.84
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 6.04
Lowest since issue 0.72
Delta0x
Omega 0.000000
Premium0x
Gearing0x
Moneyness 1.149
Difference Strike -52.12 $
Difference Strike %-14.89%
Intrinsic value 4.804

Company Profile

Intuitive Surgical, Inc. specializes in the design, manufacturing, and marketing of robotic surgical assistance video systems. The systems consist of a surgical console, arm, remote-controlled endoscope, and 3D visual immersion system. Net sales break down by activity as follows: - sale of instruments and accessories (60%): primarily wrist cuffs; - sale of robotic systems (23.6%): systems marketed under the da Vinci brand (1,370 units sold in 2023) and intended primarily for urological, cardio-thoracic, and gynecological surgeries; - installation and training services (16.4%). The United States accounts for 65.8% of net sales.
Sector
-
More about the company

Ratings for Intuitive Surgical, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Intuitive Surgical, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
402.1 USD
Average target price
423.6 USD
Spread / Average Target
+5.33%
Consensus